Bing

SEARCH HISTORY

Stocks are enjoying a big day following Federal Reserve Chairman Janet Yellen telling investors exactly what they wanted to hear: The economy is improving but big rate hikes aren’t in the cards. That turned the green light to speculators back on. The ...
USA TODAY MONEY · ByMatt Krantz · 6/18/2015
Shares of Fitbit Inc. (NYSE:FIT) soared nearly 50 percent Thursday after the maker of wearable health-tracking devices made its stock market debut, closing at $29.68, well above its initial public offering price of $20. The San Francisco-based company is ...
International Business Times · 6/18/2015
Amgen (NASDAQ:AMGN) inched up 0.5 percent to $160.98 after the biotechnology company said its drug met the main goal of improving overall survival in metastatic colorectal cancer patients who have not responded to chemotherapy. ConAgra Foods …
Proactive Investors Australia · 6/20/2015
More from Bing News
Biotech giant Amgen Inc. said it would lay off up to 2,900 employees and close facilities in Washington state and Colorado, as the Thousand Oaks company moved to reign in expenses and focus on new drugs. Those cuts could amount to nearly 15% of its …
Los Angeles Times · ByStuart Pfeifer · 7/29/2014
Armstrong World Industries Inc. (AWI) experienced unusually high volume on Jun. 16, as the stock gained 0.28% to a closing price of $53.83. The stock saw 929,886 shares trade hands over the course of the day on 6,382 trades. Given that the stock’s ...
Equities · 6/16/2015
The sultry days of summer are just around the corner, but Wall Street approaches this season firing on all cylinders. Both the Dow Jones and the S&P 500 are within striking distance of all-time highs, and the NASDAQ is just shy of its 52-week high ...
Market Intelligence Center · 5/29/2015
David W. Hunter founded Hunter Associates, Inc., in July 1992, after 37 years in the securities industry. He started his career in 1954 as a Stockbroker with McKelvy & Company, where he had become a Partner and Manager of the underwriting, research and ...
The Wall Street Transcript · 11/7/2012
Two months ago, the FDA approved a pill from Pfizer (PFE) called Xeljanz that is being used to treat adults with moderately to severely rheumatoid arthritis who did not respond to, or cannot tolerate, methotrexate, a standard of care. Some Wall Streeters ...
YCharts · 1/3/2013

Amgen

Company
Amgen is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. Locate…
Amgen is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. Located in the Conejo Valley, Amgen is the world's largest independent biotechnology firm. In 2013, the company's largest selling product lines were Neulasta/Neupogen, two closely related drugs used to prevent infections in patients undergoing cancer chemotherapy; and Enbrel, a tumor necrosis factor blocker used in the treatment of rheumatoid arthritis and other autoimmune diseases. Other products include Epogen, Aranesp, Sensipar/Mimpara, Nplate, Vectibix, Prolia and XGEVA.
Data from: Wikipedia